Making everyday life significantly better

Discover our purpose
Sharon, person with Parkinson’s, unstoppable on the court

At Adamas, we are passionate about improving lives and making a meaningful difference for people affected by neurological diseases. We leverage our experience in drug discovery, development and commercialization to deliver innovative medicines that reduce the burden on patients, caregivers, and society, and build a foundation for growth.

About GOCOVRI®

GOCOVRI (amantadine) extended release capsules is the first and only FDA approved treatment for dyskinesia in Parkinson’s disease patients treated with levodopa therapy, with or without other medicines that increase the effects of dopamine in the brain. GOCOVRI is also clinically proven to treat dyskinesia while also reducing OFF time in PD.

Our culture

See what it means to work with passionate, dedicated and spirited people who share a strong sense of purpose.

Investors

Our Investor Hub is designed to help you easily find the most important information about our company.

Latest news

Press release

Adamas provides program update for ADS-5102 for Multiple Sclerosis patients with walking impairment

June 17, 2020

EMERYVILLE, Calif., June 17, 2020 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced the completion of its evaluation of ADS-5102 in multiple sclerosis patients with walking impairment (MSW).

Media coverage

Gocovri Before FDA as Possible Bedtime Therapy for ‘Off’ Time in Parkinson’s

June 8, 2020

The U.S. Food and Drug Administration (FDA) has agreed to review Adamas Pharmaceutical’s application asking that oral Gocovri (amantadine) also be approved to treat off episodes in Parkinson’s disease patients using levodopa.

Parkinson’s News Today

Media coverage

Largest Biopharma Companies in the Greater Bay Area

May 22, 2020

Ranked by Bay Area employees Locally Researched by: Ahalya Srikant, San Francisco Business Times May 22, 2020, 3:00am PDT This List includes biopharmaceutical companies located in the Greater Bay Area, which is defined as Alameda, Contra Costa, Marin, Napa, San Francisco, San Mateo, Santa Clara, Solano and Sonoma counties.

Bizjournal

Supporting the Parkinson's community

Parkinson’s Moving Day San Francisco
Parkinson’s Unity Walk
The Michael J. Fox Foundation Tour de Fox

What's New